264 related articles for article (PubMed ID: 23445171)
21. An optimized mesoporous silica nanosphere-based carrier system with chemically removable Au nanoparticle caps for redox-stimulated and targeted drug delivery.
Zhang L; Wei F; Al-Ammari A; Sun D
Nanotechnology; 2020 Nov; 31(47):475102. PubMed ID: 32413886
[TBL] [Abstract][Full Text] [Related]
22. PEG-templated mesoporous silica nanoparticles exclusively target cancer cells.
Morelli C; Maris P; Sisci D; Perrotta E; Brunelli E; Perrotta I; Panno ML; Tagarelli A; Versace C; Casula MF; Testa F; Andò S; Nagy JB; Pasqua L
Nanoscale; 2011 Aug; 3(8):3198-207. PubMed ID: 21725561
[TBL] [Abstract][Full Text] [Related]
23. γ-PGA-coated mesoporous silica nanoparticles with covalently attached prodrugs for enhanced cellular uptake and intracellular GSH-responsive release.
Du X; Xiong L; Dai S; Qiao SZ
Adv Healthc Mater; 2015 Apr; 4(5):771-81. PubMed ID: 25582379
[TBL] [Abstract][Full Text] [Related]
24. Poly(propylene imine) dendrimer caps on mesoporous silica nanoparticles for redox-responsive release: smaller is better.
Nadrah P; Porta F; Planinšek O; Kros A; Gaberšček M
Phys Chem Chem Phys; 2013 Jul; 15(26):10740-8. PubMed ID: 23689395
[TBL] [Abstract][Full Text] [Related]
25. Mesoporous Silica Platforms with Potential Applications in Release and Adsorption of Active Agents.
Chircov C; Spoială A; Păun C; Crăciun L; Ficai D; Ficai A; Andronescu E; Turculeƫ ȘC
Molecules; 2020 Aug; 25(17):. PubMed ID: 32825791
[TBL] [Abstract][Full Text] [Related]
26. Cytochrome c end-capped mesoporous silica nanoparticles as redox-responsive drug delivery vehicles for liver tumor-targeted triplex therapy in vitro and in vivo.
Zhang B; Luo Z; Liu J; Ding X; Li J; Cai K
J Control Release; 2014 Oct; 192():192-201. PubMed ID: 25034575
[TBL] [Abstract][Full Text] [Related]
27. The intracellular controlled release from bioresponsive mesoporous silica with folate as both targeting and capping agent.
Guo R; Li LL; Zhao WH; Chen YX; Wang XZ; Fang CJ; Feng W; Zhang TL; Ma X; Lu M; Peng SQ; Yan CH
Nanoscale; 2012 Jun; 4(11):3577-83. PubMed ID: 22543578
[TBL] [Abstract][Full Text] [Related]
28. Gated mesoporous silica nanoparticles for the controlled delivery of drugs in cancer cells.
Giménez C; de la Torre C; Gorbe M; Aznar E; Sancenón F; Murguía JR; Martínez-Máñez R; Marcos MD; Amorós P
Langmuir; 2015 Mar; 31(12):3753-62. PubMed ID: 25742160
[TBL] [Abstract][Full Text] [Related]
29. Hindered disulfide bonds to regulate release rate of model drug from mesoporous silica.
Nadrah P; Maver U; Jemec A; Tišler T; Bele M; Dražić G; Benčina M; Pintar A; Planinšek O; Gaberšček M
ACS Appl Mater Interfaces; 2013 May; 5(9):3908-15. PubMed ID: 23581883
[TBL] [Abstract][Full Text] [Related]
30. UV-light cross-linked and pH de-cross-linked coumarin-decorated cationic copolymer grafted mesoporous silica nanoparticles for drug and gene co-delivery in vitro.
Zhou S; Ding C; Wang C; Fu J
Mater Sci Eng C Mater Biol Appl; 2020 Mar; 108():110469. PubMed ID: 31923958
[TBL] [Abstract][Full Text] [Related]
31. Thermo-responsive mesoporous silica/lipid bilayer hybrid nanoparticles for doxorubicin on-demand delivery and reduced premature release.
Zhang Q; Chen X; Shi H; Dong G; Zhou M; Wang T; Xin H
Colloids Surf B Biointerfaces; 2017 Dec; 160():527-534. PubMed ID: 29024917
[TBL] [Abstract][Full Text] [Related]
32. Polydopamine-based surface modification of mesoporous silica nanoparticles as pH-sensitive drug delivery vehicles for cancer therapy.
Chang D; Gao Y; Wang L; Liu G; Chen Y; Wang T; Tao W; Mei L; Huang L; Zeng X
J Colloid Interface Sci; 2016 Feb; 463():279-87. PubMed ID: 26550786
[TBL] [Abstract][Full Text] [Related]
33. Controlled release of silyl ether camptothecin from thiol-ene click chemistry-functionalized mesoporous silica nanoparticles.
Yan Y; Fu J; Wang T; Lu X
Acta Biomater; 2017 Mar; 51():471-478. PubMed ID: 28131940
[TBL] [Abstract][Full Text] [Related]
34. Mesoporous silica nanoparticles combining Au particles as glutathione and pH dual-sensitive nanocarriers for doxorubicin.
Xu S; Li Y; Chen Z; Hou C; Chen T; Xu Z; Zhang X; Zhang H
Mater Sci Eng C Mater Biol Appl; 2016 Feb; 59():258-264. PubMed ID: 26652372
[TBL] [Abstract][Full Text] [Related]
35. pH and Glutathione Dual-Responsive Dynamic Cross-Linked Supramolecular Network on Mesoporous Silica Nanoparticles for Controlled Anticancer Drug Release.
Li QL; Xu SH; Zhou H; Wang X; Dong B; Gao H; Tang J; Yang YW
ACS Appl Mater Interfaces; 2015 Dec; 7(51):28656-64. PubMed ID: 26633741
[TBL] [Abstract][Full Text] [Related]
36. CdS/TiO2-fluorescein isothiocyanate nanoparticles as fluorescence resonance energy transfer probe for the determination of trace alkaline phosphatase based on affinity adsorption assay.
Liu JM; Lin LP; Jiao L; Cui ML; Wang XX; Zhang LH; Zheng ZY
Talanta; 2012 Aug; 98():137-44. PubMed ID: 22939139
[TBL] [Abstract][Full Text] [Related]
37. A comparison of mesoporous silica nanoparticles and mesoporous organosilica nanoparticles as drug vehicles for cancer therapy.
Yue J; Luo SZ; Lu MM; Shao D; Wang Z; Dong WF
Chem Biol Drug Des; 2018 Aug; 92(2):1435-1444. PubMed ID: 29671941
[TBL] [Abstract][Full Text] [Related]
38. Polymer-Brush-Grafted Mesoporous Silica Nanoparticles for Triggered Drug Delivery.
Zhang L; Bei HP; Piao Y; Wang Y; Yang M; Zhao X
Chemphyschem; 2018 Aug; 19(16):1956-1964. PubMed ID: 29575338
[TBL] [Abstract][Full Text] [Related]
39. A dual-sensitive mesoporous silica nanoparticle based drug carrier for cancer synergetic therapy.
Zhang J; Shen B; Chen L; Chen L; Meng Y; Feng J
Colloids Surf B Biointerfaces; 2019 Mar; 175():65-72. PubMed ID: 30522009
[TBL] [Abstract][Full Text] [Related]
40. Fluorescent carbon dot-gated multifunctional mesoporous silica nanocarriers for redox/enzyme dual-responsive targeted and controlled drug delivery and real-time bioimaging.
Wang Y; Cui Y; Zhao Y; He B; Shi X; Di D; Zhang Q; Wang S
Eur J Pharm Biopharm; 2017 Aug; 117():105-115. PubMed ID: 28363599
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
